We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$6.49B
AUM Growth
+$329M
Cap. Flow
+$1.05B
Cap. Flow %
16.14%
Top 10 Hldgs %
17.7%
Holding
945
New
236
Increased
167
Reduced
92
Closed
153

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$112M
2
SWKS icon
Skyworks Solutions
SWKS
+$103M
3
STM icon
STMicroelectronics
STM
+$87.3M
4
ASML icon
ASML
ASML
+$71.6M
5
PANW icon
Palo Alto Networks
PANW
+$64.4M

Sector Composition

Rank Sector Weight
1 Healthcare 34.94%
2 Technology 31.31%
3 Financials 8.29%
4 Industrials 7.52%
5 Communication Services 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDNT icon
301
RadNet
RDNT
$5.25B
$3.75M 0.06%
217,058
-295,198
-58% -$5.74M
VAQC
302
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$3.72M 0.06%
379,501
+29,501
+8% +$289K
ESM
303
DELISTED
ESM Acquisition Corporation
ESM
$3.67M 0.06%
375,026
+25,026
+7% +$245K
ACAD icon
304
Acadia Pharmaceuticals
ACAD
$4.39B
$3.66M 0.06%
+259,967
New +$4.85M
GLUE icon
305
Monte Rosa Therapeutics
GLUE
$1.3B
$3.64M 0.06%
376,008
+327,908
+682% +$3.29M
OM icon
306
Outset Medical
OM
$92.5M
$3.62M 0.06%
16,224
-4,429
-21% -$1.91M
ROP icon
307
Roper Technologies
ROP
$38.8B
$3.61M 0.06%
+9,151
New +$3.98M
IGMS
308
DELISTED
IGM Biosciences
IGMS
$3.61M 0.06%
200,047
-203,354
-50% -$3.62M
SMIH
309
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
$3.58M 0.06%
367,600
MDB icon
310
MongoDB
MDB
$28.8B
$3.52M 0.05%
13,569
-13,150
-49% -$4.11M
JANX icon
311
Janux Therapeutics
JANX
$934M
$3.5M 0.05%
286,383
+8,060
+3% +$95.4K
INFN
312
DELISTED
Infinera Corporation Common Stock
INFN
$3.47M 0.05%
+647,289
New +$4.14M
SGHL
313
DELISTED
Signal Hill Acquisition Corp. Class A Common Stock
SGHL
$3.46M 0.05%
+350,000
New +$3.48M
ACHC icon
314
Acadia Healthcare
ACHC
$2.85B
$3.45M 0.05%
+51,061
New +$3.56M
SDST
315
Stardust Power Inc
SDST
$7.4M
$3.44M 0.05%
35,000
ZLS
316
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$3.44M 0.05%
354,215
CNK icon
317
Cinemark Holdings
CNK
$4.39B
$3.44M 0.05%
+228,851
New +$3.63M
FRON
318
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$3.43M 0.05%
350,000
ATEK
319
DELISTED
Athena Technology Acquisition Corp. II
ATEK
$3.43M 0.05%
350,000
SLCR
320
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$3.3M 0.05%
334,709
EVH icon
321
Evolent Health
EVH
$353M
$3.28M 0.05%
+106,897
New +$3.11M
KNTE
322
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$3.28M 0.05%
260,276
KNSA icon
323
Kiniksa Pharmaceuticals
KNSA
$5.73B
$3.23M 0.05%
+332,893
New +$3.11M
FSNB
324
DELISTED
Fusion Acquisition Corp. II
FSNB
$3.19M 0.05%
324,992
LGV
325
DELISTED
Longview Acquisition Corp. II
LGV
$3.17M 0.05%
325,000

Similar funds

Woodline Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Woodline Partners held 945 positions worth $6.49B, up 5.3% from $6.16B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Woodline Partners deployed $1.05B of net new capital in Q2 2022, opening 236 new positions and adding to 167 existing holdings. Its largest new stake was Skyworks Solutions: 955,660 shares worth $88.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $169M trimmed.

  • Woodline Partners's largest Q2 2022 buy was Skyworks Solutions: 955,660 shares worth $88.5M.
  • Woodline Partners added most to Eli Lilly in Q2 2022, an estimated $112M increase.
  • Woodline Partners's biggest Q2 2022 reduction was Seagen Inc. Common Stock, cutting an estimated $169M.
  • Woodline Partners fully exited Cooper Companies in Q2 2022, selling an estimated $103M.
  • Woodline Partners's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2022.
  • Woodline Partners opened 236 new positions and closed 153 in Q2 2022.
  • Woodline Partners's portfolio value rose 5.3% quarter-over-quarter to $6.49B.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.